To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SLC39A3andDIRAS1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
487 supporting clones for gene SLC39A3andDIRAS1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BQ898834 brain, neuroblastoma, cell line .a 1 to 760 1 to 769   tiling clone,   769/932
(82 %)
16 diff
(98.3 %id)
BI457895 brain, hypothalamus .a 72 to 780 1 to 709       709/709
(100 %)
7 diff
(99.1 %id)
BI596675 brain, hypothalamus .a 72 to 700 1 to 629       629/629
(100 %)
5 diff
(99.3 %id)
DB496031 hypothalamus .a 77 to 540 1 to 464       464/476
(97 %)
1 diff
(99.8 %id)
BI599519 brain, hypothalamus .a 77 to 914 6 to 835       830/863
(96 %)
23 diff
(97.4 %id)
TI_45209103   .a 77 to 700 92 to 715       624/715
(87 %)
6 diff
(99.2 %id)
TI_45211650   .a 77 to 914 94 to 923       830/951
(87 %)
23 diff
(97.6 %id)
NM_144564.4   .a 77 to 1499 1 to 1423   RefSeq, AAA   1423/1423
(100 %)
0 diff
(100 %id)
CB990841 placenta, pre-eclamptic placenta .a 83 to 690 27 to 640       614/814
(75 %)
25 diff
(97.0 %id)
TI_57220567   .a 83 to 1005 20 to 941       922/942
(97 %)
20 diff
(97.9 %id)
BI463188 testis .a 84 to 653 1 to 578       578/700
(82 %)
16 diff
(97.8 %id)
DB444366 testis .a 89 to 540 1 to 452       452/461
(98 %)
1 diff
(99.8 %id)
BE734610 choriocarcinoma, placenta .a 89 to 811 1 to 730       730/730
(100 %)
35 diff
(95.3 %id)
BI753565 brain .a 90 to 782 1 to 690       690/690
(100 %)
4 diff
(99.5 %id)
TI_57219795   .a 90 to 782 29 to 718       690/718
(96 %)
7 diff
(99.1 %id)
AL557685 T cells (Jurkat cell line), T cells from T cell leukemia .a 91 to 708 1 to 618       618/618
(100 %)
3 diff
(99.6 %id)
BF529564 anaplastic oligodendroglioma with 1p/19qloss, brain .a 91 to 701 1 to 615       615/615
(100 %)
4 diff
(99.4 %id)
BI464808 testis .a 93 to 749 1 to 652       652/652
(100 %)
9 diff
(98.7 %id)
BP368960 testis .a 94 to 661 1 to 568       568/568
(100 %)
1 diff
(99.9 %id)
CX751212 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 95 to 789 37 to 731       695/731
(95 %)
6 diff
(99.2 %id)
BQ217868 epithelioid carcinoma, Pancreas .a 97 to 850 1 to 758       758/852
(88 %)
11 diff
(98.8 %id)
BU528122 epidermoid carcinoma, cell line, lung .a 97 to 918 1 to 829       829/922
(89 %)
35 diff
(96.3 %id)
DB502775 hypothalamus .a 98 to 585 1 to 489       489/489
(100 %)
2 diff
(99.6 %id)
BI757354 brain .a 98 to 1005 1 to 907       907/908
(99 %)
13 diff
(98.6 %id)
BP382189 adipose tissue .a 99 to 682 1 to 585       585/585
(100 %)
24 diff
(95.9 %id)
DA617694   .a 99 to 671 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
BG719479 testis .a 100 to 649 1 to 550       550/550
(100 %)
4 diff
(99.3 %id)
BP370834 testis .a 102 to 653 1 to 552       552/555
(99 %)
5 diff
(99.1 %id)
CN255737 embryonic stem cells, cell lines H1, H7, andH9 .a 104 to 719 1 to 617       617/617
(100 %)
3 diff
(99.6 %id)
BG528510 adenocarcinoma, Prostate .a 104 to 830 1 to 736       735/751
(97 %)
36 diff
(95.3 %id)
BM915123 amelanotic melanoma, cell line, skin .a 104 to 895 7 to 804       798/1068
(74 %)
46 diff
(95.7 %id)
BP253909 Kidney .a 105 to 659 1 to 555       555/555
(100 %)
6 diff
(99.0 %id)
BG829533 epithelioid carcinoma cell line, Pancreas .a 105 to 856 1 to 752       752/816
(92 %)
17 diff
(98.0 %id)
BG830657 epithelioid carcinoma cell line, Pancreas .a 105 to 895 1 to 787       787/791
(99 %)
14 diff
(98.3 %id)
DR156876 human embryonic stem cells differentiated toan early endodermal cell type .a 107 to 843 1 to 737       737/737
(100 %)
0 diff
(100 %id)
BP251956 Kidney .a 109 to 692 1 to 584       584/584
(100 %)
2 diff
(99.7 %id)
DA692478   .a 110 to 560 2 to 452   capped   451/451
(100 %)
1 diff
(99.8 %id)
BI832389 brain, medulla .a 113 to 912 19 to 821       803/1274
(63 %)
32 diff
(97.5 %id)
TI_57171222   .a 113 to 912 19 to 821       803/1274
(63 %)
32 diff
(97.5 %id)
BM423900 amelanotic melanoma, cell line, skin .a 114 to 1022 1 to 924       924/1026
(90 %)
32 diff
(96.9 %id)
CR618109 T cells (Jurkat cell line) Cot10-normalized .a 115 to 1460 1 to 1346       1346/1346
(100 %)
0 diff
(100 %id)
BX462525 T cells (Jurkat cell line) .a 115 to 1094 1 to 961       961/1044
(92 %)
22 diff
(97.9 %id)
BX340981   .a 115 to 769 1 to 656   fully sequenced,   656/656
(100 %)
1 diff
(99.9 %id)
BG774039 choriocarcinoma, placenta .a 117 to 758 1 to 641       641/641
(100 %)
3 diff
(99.6 %id)
BE410251 choriocarcinoma, placenta .a 118 to 728 1 to 614       614/615
(99 %)
11 diff
(98.3 %id)
TI_57171399   .a 120 to 917 56 to 852       797/852
(93 %)
13 diff
(98.5 %id)
CN255763 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 125 to 721 1 to 597       597/597
(100 %)
2 diff
(99.7 %id)
AL527727 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 125 to 779 1 to 654   fully sequenced,   654/654
(100 %)
5 diff
(99.3 %id)
AL555254 placenta .a 131 to 707 1 to 577       577/577
(100 %)
4 diff
(99.4 %id)
BG722282 testis .a 131 to 775 1 to 645       645/645
(100 %)
4 diff
(99.4 %id)
CA488209   .a 132 to 819 1 to 691       691/987
(70 %)
14 diff
(98.6 %id)
BI830404 brain, medulla .a 134 to 917 1 to 783       783/783
(100 %)
7 diff
(99.2 %id)
BF345859 anaplastic oligodendroglioma with 1p/19qloss, brain .a 135 to 961 1 to 816       816/878
(92 %)
22 diff
(97.5 %id)
BG718493 testis .a 135 to 919 1 to 789       789/793
(99 %)
18 diff
(97.8 %id)
CB155213 brain .a 136 to 652 1 to 517       517/517
(100 %)
0 diff
(100 %id)
BP208882 cerebellum .a 136 to 714 1 to 579       579/579
(100 %)
7 diff
(98.8 %id)
BP340633 Spleen .a 136 to 719 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
DA365681 subthalamic nucleus .a 137 to 707 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
BE279503 choriocarcinoma, placenta .a 137 to 793 1 to 653       653/716
(91 %)
9 diff
(98.8 %id)
BE279534 choriocarcinoma, placenta .a 137 to 835 1 to 696       696/698
(99 %)
12 diff
(98.3 %id)
DB072162 testis .a 137 to 680 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
AA450159   .a 140 to 574 1 to 431       431/431
(100 %)
4 diff
(99.1 %id)
AL528557 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 142 to 944 1 to 799   fully sequenced,   799/799
(100 %)
4 diff
(99.5 %id)
BC005869 Lymph, Burkitt lymphoma .a 145 to 1499 1 to 1355   available from MGC, AAA   1355/1355
(100 %)
0 diff
(100 %id)
CR598984 Neuroblastoma Cot 10-normalized .a 145 to 1471 1 to 1327       1327/1327
(100 %)
0 diff
(100 %id)
AL520141 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 145 to 768 1 to 616   fully sequenced,   616/616
(100 %)
0 diff
(100 %id)
BC000085 Brain, neuroblastoma .a 145 to 1499 518 to 1872   tiling clone, AAA   1355/1872
(72 %)
6 diff
(99.7 %id)
N78275 liver and spleen .a 149 to 522 1 to 374       374/380
(98 %)
6 diff
(98.5 %id)
BE019433 muscle, rhabdomyosarcoma .a 150 to 678 1 to 529       529/529
(100 %)
0 diff
(100 %id)
CR591971 HeLa cells Cot 25-normalized .a 155 to 1466 1 to 1312       1312/1312
(100 %)
0 diff
(100 %id)
CR602071 neuroblastoma .a 155 to 1473 1 to 1319       1319/1319
(100 %)
0 diff
(100 %id)
AL516369 brain, neuroblastoma, neuroblastoma cells .a 155 to 902 1 to 749   fully sequenced,   749/749
(100 %)
3 diff
(99.6 %id)
BM702112 eye, optic nerve .a 157 to 691 1 to 535       535/537
(99 %)
5 diff
(99.1 %id)
R35388 whole brain .a 162 to 540 1 to 380       380/441
(86 %)
6 diff
(98.7 %id)
BE270836 Burkitt lymphoma, lymph .a 165 to 913 1 to 743   fully sequenced,   743/743
(100 %)
9 diff
(98.8 %id)
W03418 melanocyte .a 173 to 625 1 to 452       452/452
(100 %)
5 diff
(98.9 %id)
BX386641   .a 383 to 1466 1075 to 1       1075/1097
(97 %)
41 diff
(96.3 %id)
BX425343 neuroblastoma .a 419 to 1424 1 to 1002       1002/1066
(93 %)
43 diff
(96.0 %id)
CR591681 neuroblastoma .a 419 to 1496 1 to 1078       1078/1078
(100 %)
0 diff
(100 %id)
BM709085 eye, optic nerve .a 428 to 913 1 to 486   fully sequenced,   486/486
(100 %)
1 diff
(99.8 %id)
AA431176   .a 540 to 762 14 to 238       225/238
(94 %)
6 diff
(97.5 %id)
BX362491   .a 541 to 1457 917 to 1       917/917
(100 %)
29 diff
(96.9 %id)
TI_154106365   .a 543 to 1499 1016 to 75   AAA   942/962
(97 %)
27 diff
(97.2 %id)
AF052125 brain .a 553 to 1499 1 to 947   AAA   947/947
(100 %)
0 diff
(100 %id)
BE620569 large cell carcinoma, undifferentiated, lung .a 641 to 1435 817 to 6       812/845
(96 %)
0 diff
(100 %id)
BM726550 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 647 to 978 1 to 332   fully sequenced,   332/332
(100 %)
0 diff
(100 %id)
TI_154108458   .a 655 to 1499 919 to 82   AAA   838/955
(87 %)
8 diff
(99.2 %id)
BU849000 ovary, teratocarcinoma, cell line .a 663 to 1397 1 to 751       751/941
(79 %)
17 diff
(98.2 %id)
TI_149301843   .a 663 to 1499 916 to 88   AAA   829/963
(86 %)
15 diff
(98.5 %id)
TI_149286877   .a 713 to 1486 828 to 64   AAA   765/1061
(72 %)
12 diff
(98.9 %id)
AI345973 adenocarcinoma, colon .a 727 to 1493 768 to 1       768/874
(87 %)
50 diff
(94.3 %id)
AA243831 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 728 to 1177 1 to 437   fully sequenced,   437/437
(100 %)
15 diff
(96.6 %id)
BM710092 eye, optic nerve .a 730 to 1068 1 to 339   fully sequenced,   339/339
(100 %)
4 diff
(98.9 %id)
AL561856 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 738 to 1471 730 to 1   fully sequenced,   730/730
(100 %)
12 diff
(98.4 %id)
BX340980   .a 739 to 1457 719 to 2   fully sequenced,   718/719
(99 %)
6 diff
(99.2 %id)
CA447580 Chondrosarcoma, Left Pelvis .a 741 to 1499 775 to 19   AAA   757/757
(100 %)
2 diff
(99.8 %id)
AL527726 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 749 to 1470 716 to 1   fully sequenced,   716/716
(100 %)
6 diff
(99.2 %id)
CA446754 Chondrosarcoma, Left Pubic Bone .a 757 to 1499 760 to 19   AAA   742/742
(100 %)
3 diff
(99.6 %id)
AL579666 T cells (Jurkat cell line), T cells from T cell leukemia .a 799 to 1330 681 to 147       535/681
(78 %)
0 diff
(100 %id)
BM980135 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 818 to 1499 700 to 19   AAA   682/682
(100 %)
2 diff
(99.8 %id)
AI479662 B-cell, chronic lymphotic leukemia .a 832 to 1500 669 to 1       669/669
(100 %)
10 diff
(98.6 %id)
CB853685 Human Lung Epithelial cells, lung .a 833 to 1499 686 to 19   AAA   668/668
(100 %)
1 diff
(99.9 %id)
BF002495 colon, colon tumor, RER+ .a 842 to 1490 651 to 3       649/651
(99 %)
0 diff
(100 %id)
AL577796 placenta .a 845 to 1454 626 to 18       609/626
(97 %)
7 diff
(98.9 %id)
AW515776 pooled germ cell tumors .a 847 to 1499 653 to 1       653/653
(100 %)
14 diff
(97.9 %id)
BQ575165 Chondrosarcoma Grade II, Left Pelvis .a 849 to 1486 656 to 19   AAA   638/638
(100 %)
0 diff
(100 %id)
BU729643.
matches multiple genes
eye, optic nerve .a 851 to 1499 667 to 19   AAA also hits gene ATXN2L 649/649
(100 %)
4 diff
(99.4 %id)
BU632023 cell lines, Chondrosarcoma .a 851 to 1499 666 to 19   AAA   648/648
(100 %)
3 diff
(99.6 %id)
BU622567 cell lines, Chondrosarcoma .a 852 to 1499 665 to 19   AAA   647/647
(100 %)
4 diff
(99.4 %id)
BQ000176 Fibrosarcoma .a 854 to 1499 667 to 19   AAA   649/649
(100 %)
2 diff
(99.7 %id)
CA306393 Alveolar Macrophage, lung .a 855 to 1499 663 to 19   AAA   645/645
(100 %)
0 diff
(100 %id)
BM972291 lung .a 860 to 1486 641 to 19   AAA   623/623
(100 %)
4 diff
(99.4 %id)
BQ227957 epithelioid carcinoma, Pancreas .a 863 to 1490 1 to 628       628/919
(68 %)
2 diff
(99.8 %id)
BX330948   .a 864 to 1496 640 to 5       636/781
(81 %)
0 diff
(100 %id)
BF310836 brain, neuroblastoma .a 870 to 1499 1 to 625   AAA   625/625
(100 %)
11 diff
(98.3 %id)
AL516368 brain, neuroblastoma, neuroblastoma cells .a 872 to 1456 603 to 15   fully sequenced,   589/603
(97 %)
14 diff
(97.7 %id)
BE271021 Burkitt lymphoma, lymph .a 883 to 1435 565 to 16   fully sequenced,   550/565
(97 %)
0 diff
(100 %id)
BM509943 Pancreas, Purified pancreatic islet .a 886 to 1495 610 to 1       610/610
(100 %)
1 diff
(99.9 %id)
AI949416 2 pooled tumors (clear cell type), Kidney .a 887 to 1502 617 to 2       616/622
(99 %)
0 diff
(100 %id)
BE297201 muscle, rhabdomyosarcoma .a 891 to 1499 1 to 639   AAA   639/639
(100 %)
23 diff
(96.5 %id)
BQ028760 Bone, Subchondral Bone .a 898 to 1499 619 to 19   AAA   601/601
(100 %)
1 diff
(99.9 %id)
BU732552 eye, optic nerve .a 900 to 1499 616 to 19   fully sequenced, AAA   598/598
(100 %)
4 diff
(99.4 %id)
TI_154110875   .a 905 to 1499 667 to 79   AAA   589/776
(75 %)
13 diff
(98.4 %id)
BG282778 adenocarcinoma, cell line, Prostate .a 913 to 1499 1 to 585   AAA   585/585
(100 %)
5 diff
(99.2 %id)
AL528556 brain, neuroblastoma cells, Neuroblastoma Cot 50-normalized .a 914 to 1487 586 to 1   fully sequenced,   586/586
(100 %)
27 diff
(95.4 %id)
AI221493 pooled .a 916 to 1489 574 to 1       574/577
(99 %)
7 diff
(98.8 %id)
BI094287 cervix .a 927 to 1488 1 to 565       565/604
(93 %)
22 diff
(96.4 %id)
BG476672 melanotic melanoma, skin .a 928 to 1503 646 to 40     Submitted on the opposite strand 607/670
(90 %)
0 diff
(100 %id)
BM681204 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 948 to 1486 556 to 19   fully sequenced, AAA   538/538
(100 %)
3 diff
(99.5 %id)
BF591143 colon, colon tumor, RER+ .a 973 to 1496 527 to 4       524/527
(99 %)
0 diff
(100 %id)
BF115078 Kidney .a 974 to 1486 525 to 13   AAA   513/513
(100 %)
1 diff
(99.9 %id)
BM666697 eye, optic nerve .a 975 to 1499 543 to 19   AAA   525/525
(100 %)
1 diff
(99.9 %id)
AW138689   .a 979 to 1499 537 to 17   AAA   521/521
(100 %)
2 diff
(99.7 %id)
AA781473   .a 1006 to 1490 487 to 5       483/487
(99 %)
0 diff
(100 %id)
BF060728 pooled .a 1009 to 1498 490 to 1       490/490
(100 %)
0 diff
(100 %id)
BF446375 Prostate .a 1015 to 1499 485 to 1       485/485
(100 %)
1 diff
(99.8 %id)
CA448215 Chondrosarcoma, Left Pubic Bone .a 1026 to 1499 492 to 19   AAA   474/474
(100 %)
2 diff
(99.6 %id)
AI394563 B-cell, chronic lymphotic leukemia .a 1028 to 1498 471 to 1       471/471
(100 %)
3 diff
(99.4 %id)
DB573984 hypothalamus .a 1029 to 1499 1 to 471     Submitted on the opposite strand 471/471
(100 %)
3 diff
(99.4 %id)
AA987860 Kidney, kidney tumor .a 1032 to 1476 445 to 1       445/447
(99 %)
12 diff
(97.4 %id)
DB567039 hypothalamus .a 1035 to 1499 1 to 465     Submitted on the opposite strand 465/465
(100 %)
2 diff
(99.6 %id)
BE206032 muscle, rhabdomyosarcoma .a 1036 to 1502 468 to 2       467/468
(99 %)
0 diff
(100 %id)
BM671256 eye, optic nerve .a 1038 to 1499 479 to 19   fully sequenced, AAA   461/461
(100 %)
0 diff
(100 %id)
AW874315 tumor, uterus .a 1039 to 1501 463 to 1       463/465
(99 %)
2 diff
(99.6 %id)
AI826836 normal prostate, Prostate .a 1043 to 1495 470 to 17   AAA   454/454
(100 %)
13 diff
(97.2 %id)
AW073549 connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma .a 1054 to 1499 446 to 1       446/446
(100 %)
4 diff
(99.2 %id)
DB546095 hippocampus .a 1056 to 1499 1 to 444     Submitted on the opposite strand 444/444
(100 %)
1 diff
(99.8 %id)
AI005328 pooled .a 1060 to 1502 444 to 2       443/444
(99 %)
0 diff
(100 %id)
N59534 liver and spleen .a 1064 to 1499 434 to 1       434/436
(99 %)
9 diff
(98.0 %id)
AW083797 colon, moderately differentiated adenocarcinoma .a 1067 to 1490 425 to 2       424/425
(99 %)
0 diff
(100 %id)
CA422022 Bone, Enchondroma cell line .a 1074 to 1499 444 to 19   AAA   426/426
(100 %)
1 diff
(99.8 %id)
DB546661 hippocampus .a 1078 to 1499 1 to 422     Submitted on the opposite strand 422/422
(100 %)
0 diff
(100 %id)
AI419801 pooled .a 1089 to 1502 414 to 4       411/414
(99 %)
0 diff
(100 %id)
AI924531 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 1090 to 1499 434 to 25   AAA   410/410
(100 %)
2 diff
(99.6 %id)
AI798158 pooled .a 1092 to 1490 397 to 1       397/397
(100 %)
5 diff
(98.8 %id)
AI863641 Kidney .a 1095 to 1500 407 to 1       407/407
(100 %)
3 diff
(99.3 %id)
AW594586 pooled germ cell tumors .a 1101 to 1497 399 to 3       397/399
(99 %)
0 diff
(100 %id)
AI689053 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 1104 to 1499 396 to 1       396/396
(100 %)
0 diff
(100 %id)
AW573181 pooled .a 1106 to 1502 397 to 1       397/397
(100 %)
2 diff
(99.5 %id)
R49689 whole brain .a 1109 to 1502 401 to 6       396/406
(97 %)
0 diff
(100 %id)
AA913733 pooled .a 1111 to 1493 383 to 4       380/383
(99 %)
0 diff
(100 %id)
AA960875 pooled .a 1111 to 1499 389 to 1       389/389
(100 %)
10 diff
(97.5 %id)
BE465963 pooled germ cell tumors .a 1116 to 1494 381 to 3       379/381
(99 %)
0 diff
(100 %id)
AI089019 pooled .a 1117 to 1490 375 to 2       374/375
(99 %)
0 diff
(100 %id)
AA432197   .a 1133 to 1502 370 to 1       370/370
(100 %)
5 diff
(98.7 %id)
AA865728 pooled germ cell tumors .a 1134 to 1496 358 to 1       358/358
(100 %)
7 diff
(98.1 %id)
AW438707 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 1137 to 1499 363 to 1       363/363
(100 %)
0 diff
(100 %id)
AI138819   .a 1140 to 1497 360 to 3       358/360
(99 %)
0 diff
(100 %id)
AA450097   .a 1145 to 1499 355 to 1       355/355
(100 %)
7 diff
(98.1 %id)
AA243752 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1147 to 1499 351 to 1   fully sequenced,   351/351
(100 %)
6 diff
(98.3 %id)
BQ774529 Chondrosarcoma Grade II, Left Pelvis .a 1164 to 1486 341 to 19   AAA   323/323
(100 %)
0 diff
(100 %id)
N67815 melanocyte .a 1175 to 1499 334 to 12   AAA   323/323
(100 %)
6 diff
(98.2 %id)
AW276013 lung, two pooled squamous cell carcinomas .a 1175 to 1487 313 to 1       313/313
(100 %)
0 diff
(100 %id)
AA962127 pooled germ cell tumors .a 1184 to 1496 311 to 1       311/311
(100 %)
8 diff
(97.5 %id)
AI042610 parathyroid gland, parathyroid tumor .a 1219 to 1499 300 to 20   AAA   281/281
(100 %)
4 diff
(98.6 %id)
BE671867 pooled germ cell tumors .a 1232 to 1502 271 to 1       271/271
(100 %)
5 diff
(98.2 %id)
AA481844 ovarian tumor, ovary .a 1242 to 1499 4 to 255       252/255
(98 %)
12 diff
(95.3 %id)
AI005159 pooled .a 1250 to 1502 253 to 1       253/253
(100 %)
2 diff
(99.3 %id)
AI648534 ovary, tumor, 5 pooled (see description) .a 1250 to 1500 251 to 1       251/251
(100 %)
0 diff
(100 %id)
AL560876 B cells from Burkitt lymphoma .a 1272 to 1502 609 to 840       759/840
(90 %)
28 diff
(96.7 %id)
AW055329 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 1330 to 1486 179 to 23   AAA   157/157
(100 %)
5 diff
(96.9 %id)
AA157833.
matches multiple genes
colon, tumor .a 1337 to 1476 138 to 1     also hits gene RNF216LandRBAK 138/168
(82 %)
4 diff
(97.7 %id)
AI364241 serous papillary carcinoma, high grade, 2pooled tumors, uterus .a 1386 to 1499 114 to 1       114/114
(100 %)
0 diff
(100 %id)
AW059623   .a 1431 to 1499 69 to 1       69/69
(100 %)
0 diff
(100 %id)
D19935   .a 1431 to 1502 1 to 72     Submitted on the opposite strand 72/72
(100 %)
0 diff
(100 %id)
AK302600 testis .b 1 to 1219 1 to 1219 E288G tiling clone,   1219/1219
(100 %)
2 diff
(99.9 %id)
BM923270 pooled colon, kidney, stomach .b 2 to 887 6 to 906       901/1064
(84 %)
39 diff
(96.4 %id)
DB477489 hippocampus .b 4 to 491 1 to 488       488/488
(100 %)
3 diff
(99.4 %id)
TI_57220352   .b 7 to 947 22 to 960       939/963
(97 %)
28 diff
(97.1 %id)
BI457829 brain, hypothalamus .b 8 to 784 1 to 772       772/772
(100 %)
15 diff
(98.1 %id)
BM471686 eye, retinoblastoma .b 9 to 701 1 to 695       695/1086
(63 %)
15 diff
(98.7 %id)
BU167109 melanotic melanoma, skin .b 9 to 696 9 to 703       695/888
(78 %)
27 diff
(97.0 %id)
BI824404 pooled brain, lung, testis .b 10 to 870 1 to 864       864/865
(99 %)
8 diff
(99.1 %id)
BI836059 pooled pancreas and spleen .b 10 to 822 1 to 820       820/820
(100 %)
14 diff
(98.3 %id)
TI_57200822   .b 10 to 870 44 to 907       864/908
(95 %)
14 diff
(98.5 %id)
TI_57163614   .b 10 to 822 39 to 858       820/858
(95 %)
18 diff
(98.0 %id)
AL544928 placenta, Placenta Cot 25-normalized .b 11 to 877 1 to 864       864/864
(100 %)
83 diff
(90.4 %id)
AA280713 germinal center B cell .b 11 to 420 1 to 413       413/413
(100 %)
3 diff
(99.3 %id)
BM909436 lymph, lymphoma, cell line .b 11 to 687 1 to 678       678/1114
(60 %)
14 diff
(98.8 %id)
CN255743 embryonic stem cells, DMSO-treated H9 cellline .b 12 to 664 1 to 653       653/653
(100 %)
1 diff
(99.9 %id)
CN255759 embryonic stem cells, cell lines H1, H7, andH9 .b 12 to 488 13 to 490       478/490
(97 %)
9 diff
(98.2 %id)
BI757396 brain .b 12 to 947 1 to 934       934/937
(99 %)
22 diff
(97.7 %id)
BF308516 muscle, rhabdomyosarcoma .b 13 to 748 1 to 731       731/952
(76 %)
9 diff
(99.1 %id)
BF308063 muscle, rhabdomyosarcoma .b 13 to 756 1 to 734       734/830
(88 %)
13 diff
(98.5 %id)
BF529040 anaplastic oligodendroglioma with 1p/19qloss, brain .b 13 to 772 1 to 757       757/809
(93 %)
17 diff
(97.9 %id)
BU153594 epithelioid carcinoma, Pancreas .b 13 to 703 1 to 694       694/819
(84 %)
17 diff
(98.0 %id)
CD110243 placenta, pre-eclamptic placenta .b 13 to 617 28 to 643   AAA   616/950
(64 %)
22 diff
(97.7 %id)
BP348213 brain .b 13 to 604 1 to 592       592/592
(100 %)
0 diff
(100 %id)
BI463562 testis .b 14 to 755 1 to 748       748/748
(100 %)
15 diff
(98.0 %id)
BM810307 amelanotic melanoma, cell line, skin .b 14 to 814 23 to 834       812/1179
(68 %)
38 diff
(96.8 %id)
CN255738 embryonic stem cells, cell lines H1, H7, andH9 .b 15 to 625 12 to 623       612/623
(98 %)
7 diff
(98.9 %id)
BG576134 breast, mammary adenocarcinoma, cell line .b 15 to 633 14 to 632       619/632
(97 %)
6 diff
(99.1 %id)
BI762418 pooled colon, kidney, stomach .b 15 to 947 1 to 966       964/968
(99 %)
85 diff
(91.3 %id)
TI_57151019   .b 15 to 947 33 to 998       964/1000
(96 %)
86 diff
(91.4 %id)
BI463288 testis .b 16 to 777 1 to 757       757/758
(99 %)
16 diff
(97.9 %id)
BI756460 brain .b 17 to 870 1 to 860       860/860
(100 %)
12 diff
(98.7 %id)
BM450135 melanotic melanoma, skin .b 17 to 715 1 to 705       705/1160
(60 %)
15 diff
(98.8 %id)
TI_57220309   .b 17 to 870 35 to 894       860/894
(96 %)
17 diff
(98.1 %id)
BU184570 eye, retinoblastoma .b 18 to 781 1 to 771       771/962
(80 %)
14 diff
(98.6 %id)
BU173242 eye, retinoblastoma .b 18 to 794 1 to 780       780/903
(86 %)
9 diff
(99.1 %id)
BX386642   .b 20 to 1085 1 to 1055   tiling clone,   1055/1060
(99 %)
27 diff
(97.5 %id)
BI198492 brain, neuroblastoma .b 21 to 695 1 to 681       681/682
(99 %)
14 diff
(98.0 %id)
BQ421778 epithelioid carcinoma, Pancreas .b 21 to 783 1 to 768       768/847
(90 %)
13 diff
(98.5 %id)
DA322154 hippocampus .b 22 to 629 2 to 614   capped   613/613
(100 %)
6 diff
(99.1 %id)
BE783041 eye, retinoblastoma .b 25 to 817 1 to 796       796/802
(99 %)
20 diff
(97.6 %id)
BM563865 brain, medulla .b 27 to 764 1 to 743       743/1109
(66 %)
33 diff
(97.1 %id)
CD243822 testis .b 28 to 736 15 to 736       722/941
(76 %)
32 diff
(96.6 %id)
BE513976 Burkitt lymphoma, lymph .b 29 to 681 1 to 650       650/651
(99 %)
8 diff
(98.8 %id)
BE514052 Burkitt lymphoma, lymph .b 29 to 694 1 to 662       662/666
(99 %)
6 diff
(99.1 %id)
BE561420 Burkitt lymphoma, lymph .b 29 to 892 1 to 853       853/966
(88 %)
19 diff
(98.1 %id)
BE769967 prostate_tumor .b 31 to 489 22 to 480       459/480
(95 %)
6 diff
(98.8 %id)
BP200948 amygdala .b 34 to 530 1 to 497       497/506
(98 %)
0 diff
(100 %id)
BE792986 lung, small cell carcinoma .b 36 to 849 1 to 812       812/814
(99 %)
12 diff
(98.6 %id)
BI856244 breast, mammary adenocarcinoma, cell line .b 38 to 922 1 to 890       890/890
(100 %)
27 diff
(97.0 %id)
TI_57186112   .b 38 to 922 48 to 937       890/890
(100 %)
27 diff
(97.0 %id)
BQ223747 melanotic melanoma, skin .b 39 to 557 1 to 521       521/1132
(46 %)
6 diff
(99.5 %id)
BG482150 choriocarcinoma, placenta .b 42 to 776 1 to 737       737/737
(100 %)
11 diff
(98.6 %id)
BM503795 Pancreas, Purified pancreatic islet .b 56 to 623 1 to 568       568/568
(100 %)
0 diff
(100 %id)
BI825196 brain, medulla .b 57 to 936 1 to 882       882/883
(99 %)
9 diff
(99.0 %id)
TI_57170244   .b 57 to 936 67 to 948       882/949
(92 %)
15 diff
(98.5 %id)
BX281206 brain, medulla .b 61 to 558 1 to 498       498/498
(100 %)
0 diff
(100 %id)
BE279877 choriocarcinoma, placenta .b 72 to 642 11 to 581       571/581
(98 %)
7 diff
(98.8 %id)
CD300632 testis .b 72 to 877 35 to 843       810/881
(91 %)
28 diff
(96.9 %id)
BG718024 testis .b 86 to 660 119 to 684       566/684
(82 %)
7 diff
(99.0 %id)
BE091177 breast .b 125 to 583 471 to 18     Submitted on the opposite strand 454/472
(96 %)
9 diff
(98.1 %id)
BF530762 anaplastic oligodendroglioma with 1p/19qloss, brain .b 127 to 714 1 to 585       585/585
(100 %)
4 diff
(99.4 %id)
BE620143 large cell carcinoma, undifferentiated, lung .b 175 to 752 1 to 579       579/579
(100 %)
9 diff
(98.5 %id)
BF766582 colon_est .b 246 to 552 408 to 102     Submitted on the opposite strand 307/408
(75 %)
1 diff
(99.8 %id)
CA489704   .b 259 to 1053 1 to 801       801/906
(88 %)
22 diff
(97.6 %id)
BF337721 brain, glioblastoma with EGFR amplification .b 274 to 976 1 to 709   tiling clone,   709/1176
(60 %)
15 diff
(98.8 %id)
BI827934 brain, medulla .b 288 to 1112 1 to 850       850/1015
(83 %)
40 diff
(96.1 %id)
TI_57171753   .b 288 to 1112 66 to 915       850/1080
(78 %)
46 diff
(95.8 %id)
BM796139 Ascites, stomach .b 326 to 764 1 to 439       439/439
(100 %)
0 diff
(100 %id)
BM801416 duodenal adenocarcinoma, cell line, small intestine .b 403 to 976 1 to 576       576/992
(58 %)
30 diff
(97.0 %id)
BM701978.
matches multiple genes
eye, optic nerve .b 436 to 1035 1 to 600     Possibly primed on the genome, locally A rich (21/24 A in genome downstream of last aligned base), also hits gene ATXN2L 600/600
(100 %)
1 diff
(99.9 %id)
T77180 whole brain .b 446 to 837 1 to 393       393/393
(100 %)
9 diff
(97.8 %id)
BG821040 anaplastic oligodendroglioma with 1p/19qloss, brain .b 497 to 1038 1 to 543       543/543
(100 %)
14 diff
(97.5 %id)
BG104890 adrenal cortex carcinoma, cell line, adrenal gland .b 552 to 802 1 to 254       254/254
(100 %)
6 diff
(97.7 %id)
AB076888 brain .c-u 1 to 774 1 to 774 exact tiling clone,   774/774
(100 %)
1 diff
(99.9 %id)
DT219331 brain .d 1 to 524 1 to 524 exact tiling clone,   524/524
(100 %)
0 diff
(100 %id)
CF140488 CNCAP(3)T-225 cell line, Prostate .e 1 to 472 7 to 478       472/478
(98 %)
6 diff
(98.8 %id)
CF140560 CNCAP(3)T-225 cell line, Prostate .e 1 to 487 7 to 493       487/493
(98 %)
6 diff
(98.8 %id)
TI_154170958   .e 1 to 587 86 to 677   tiling clone,   592/1046
(56 %)
11 diff
(99.0 %id)
TI_154171064   .e 1 to 631 90 to 725 S125L M138N A141P R142A H144S ... tiling clone,   636/1362
(46 %)
22 diff
(98.4 %id)
DA404739 thalamus .f 1 to 538 6 to 543 exact tiling clone, capped   542/542
(100 %)
0 diff
(100 %id)
DR007002 Spleen .f 6 to 377 9 to 380       372/380
(97 %)
9 diff
(97.7 %id)
R60376 whole brain .f 7 to 405 1 to 399       398/400
(99 %)
17 diff
(95.8 %id)
BG740036 skin .f 39 to 431 1 to 392       392/392
(100 %)
0 diff
(100 %id)
Z46197 brain, total brain .f 40 to 321 1 to 281       281/281
(100 %)
2 diff
(99.3 %id)
BM449919 melanotic melanoma, skin .f 40 to 419 1 to 380       380/1233
(30 %)
9 diff
(99.3 %id)
AA209519 colon, tumor .f 42 to 240 1 to 197       197/197
(100 %)
4 diff
(98.0 %id)
BX463285 fetal liver, Liver .f 46 to 260 1 to 215       215/215
(100 %)
0 diff
(100 %id)
BQ083169 Ascites, stomach .f 46 to 417 1 to 372       372/372
(100 %)
0 diff
(100 %id)
BE513949 Burkitt lymphoma, lymph .f 56 to 431 1 to 376       376/378
(99 %)
1 diff
(99.8 %id)
BE077117 breast .f 93 to 431 11 to 349       339/368
(92 %)
3 diff
(99.2 %id)
W96294 heart .f 113 to 428 1 to 318       318/318
(100 %)
2 diff
(99.4 %id)
BI029203 marrow .f 246 to 431 206 to 21       186/210
(88 %)
5 diff
(97.7 %id)
DA401331 thalamus .g 1 to 571 2 to 572 exact tiling clone, capped   571/571
(100 %)
2 diff
(99.7 %id)
DR002905 fetal brain .h 1 to 655 1 to 656   tiling clone,   656/656
(100 %)
7 diff
(99.0 %id)
NM_145173.3   .h 34 to 3430 1 to 3397 exact RefSeq, AAA   3397/3397
(100 %)
0 diff
(100 %id)
DA754806   .h 35 to 600 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA299119 hippocampus .h 53 to 598 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
BC030660 Brain, hippocampus .h 54 to 3430 1 to 3376 exact tiling clone, available from MGC, AAA   3376/3376
(100 %)
6 diff
(99.9 %id)
BG699685 brain, hippocampus .h 54 to 718 1 to 664       664/664
(100 %)
2 diff
(99.7 %id)
DB480690 hippocampus .h 57 to 548 1 to 492       492/492
(100 %)
1 diff
(99.8 %id)
DB481354 hippocampus .h 57 to 497 1 to 441       441/441
(100 %)
1 diff
(99.8 %id)
DB467345 hippocampus .h 63 to 516 1 to 450       450/450
(100 %)
9 diff
(98.0 %id)
DA776813.
matches multiple genes
brain .h 64 to 634 2 to 572   capped also hits gene CGN 571/571
(100 %)
0 diff
(100 %id)
DA413415 thalamus .h 68 to 598 2 to 532   capped   531/531
(100 %)
0 diff
(100 %id)
DA399901 thalamus .h 71 to 551 2 to 482   capped   481/481
(100 %)
1 diff
(99.8 %id)
DA418870 thalamus .h 71 to 639 2 to 571   capped   570/570
(100 %)
2 diff
(99.7 %id)
DA416391 thalamus .h 74 to 641 2 to 570   capped   569/569
(100 %)
3 diff
(99.5 %id)
DA196566 amygdala .h 86 to 588 2 to 506   capped   505/505
(100 %)
3 diff
(99.5 %id)
DA118703 cerebellum .h 89 to 242 2 to 156   capped   155/155
(100 %)
1 diff
(99.4 %id)
DA310695 hippocampus .h 89 to 667 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
CR749709 melanoma (MeWo cell line) .h 89 to 3419 3370 to 40 exact tiling clone, available from DKFZ, AAA Submitted on the opposite strand 3331/3331
(100 %)
3 diff
(100.0 %id)
CN340615 embryonic stem cells, cell lines H1, H7, andH9 .h 116 to 566 1 to 451       451/451
(100 %)
0 diff
(100 %id)
AA723009 pineal gland .h 142 to 595 1 to 452     Submitted on the opposite strand 452/454
(99 %)
6 diff
(98.7 %id)
AI497811 anaplastic oligodendroglioma, brain .h 142 to 611 1 to 470     Submitted on the opposite strand 470/470
(100 %)
1 diff
(99.8 %id)
AY056037 brain; anaplastic oligodendroglioma .h 192 to 788 1 to 597 exact     597/597
(100 %)
0 diff
(100 %id)
AY059641   .h 192 to 788 1 to 597 exact     597/597
(100 %)
0 diff
(100 %id)
AY180973 brain .h 192 to 788 1 to 597 exact     597/597
(100 %)
1 diff
(99.9 %id)
DB173667 kidney, tumor tissue .h 571 to 1145 2 to 578   capped   577/577
(100 %)
3 diff
(99.5 %id)
DA491787 brain .h 617 to 1128 2 to 514   capped   513/513
(100 %)
2 diff
(99.7 %id)
AK124445 cerebellum .h 723 to 3427 1 to 2705   tiling clone, available from FLJ,   2705/2705
(100 %)
1 diff
(100.0 %id)
DA065606 cerebellum .h 724 to 1239 2 to 517   capped   516/516
(100 %)
0 diff
(100 %id)
CN340613 embryonic stem cells, DMSO-treated H9 cellline .h 912 to 1252 1 to 341       341/341
(100 %)
1 diff
(99.8 %id)
DA500811 brain .h 989 to 1547 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
BM928370 hepatocellular carcinoma, cell line, Liver .h 1012 to 1791 23 to 808       786/1091
(72 %)
24 diff
(97.9 %id)
BQ064693 lymph, lymphoma, cell line .h 1013 to 1792 1 to 783       783/1008
(77 %)
13 diff
(98.8 %id)
BQ648572 hepatocellular carcinoma, cell line, Liver .h 1013 to 1400 1 to 388       388/624
(62 %)
1 diff
(99.9 %id)
BQ652017 hepatocellular carcinoma, cell line, Liver .h 1013 to 1386 1 to 375       375/627
(59 %)
2 diff
(99.7 %id)
BQ876832 hepatocellular carcinoma, cell line, Liver .h 1013 to 1836 1 to 830       830/896
(92 %)
13 diff
(98.6 %id)
BP229543 brain .h 1045 to 1627 1 to 586       586/588
(99 %)
5 diff
(99.2 %id)
BM142290 Islets of Langerhans, Pancreas .h 1045 to 1510 1 to 467       467/467
(100 %)
1 diff
(99.8 %id)
BF948925 nervous_normal .h 1147 to 1618 16 to 487       472/487
(96 %)
6 diff
(98.8 %id)
BC017484 Brain, neuroblastoma .h 1185 to 3427 1 to 2243   tiling clone, available from MGC, AAA   2243/2243
(100 %)
0 diff
(100 %id)
DA491991 brain .h 1186 to 1738 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
BE262328 brain, neuroblastoma .h 1204 to 1744 1 to 540   available from MGC,   540/760
(71 %)
7 diff
(99.1 %id)
AL833958 brain .h 1245 to 3430 1 to 2186   available from DKFZ, AAA   2186/2186
(100 %)
4 diff
(99.9 %id)
BU742519 eye, fetal eye .h 1249 to 2005 1 to 756   AAA Submitted on the opposite strand 756/756
(100 %)
3 diff
(99.7 %id)
AK124672 amygdala .h 1271 to 3426 1 to 2157   available from FLJ,   2157/2157
(100 %)
8 diff
(99.7 %id)
DA179608 amygdala .h 1272 to 1791 2 to 523   capped   522/522
(100 %)
2 diff
(99.7 %id)
BM699757 eye, lens .h 1342 to 1620 1 to 279       279/279
(100 %)
0 diff
(100 %id)
CR614848 fetal brain .h 1454 to 3373 1 to 1920       1920/1920
(100 %)
0 diff
(100 %id)
AL539513 brain, fetal brain .h 1454 to 2475 1 to 1014   fully sequenced,   1014/1014
(100 %)
11 diff
(99.0 %id)
BX645307   .h 1525 to 2052 1 to 528       528/528
(100 %)
0 diff
(100 %id)
BX952049   .h 1597 to 2207 1 to 611       611/611
(100 %)
0 diff
(100 %id)
BF338648 brain, glioblastoma with EGFR amplification .h 1674 to 2402 1 to 727       727/791
(91 %)
23 diff
(97.1 %id)
BQ433241 epithelioid carcinoma, Pancreas .h 1674 to 2505 1 to 836       836/840
(99 %)
19 diff
(97.8 %id)
BM926200 brain .h 1685 to 2377 1 to 697       697/1159
(60 %)
27 diff
(97.7 %id)
CN340614 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .h 1771 to 2370 1 to 600       600/600
(100 %)
1 diff
(99.9 %id)
DA073434 cerebellum .h 1836 to 2396 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
BE782113 eye, retinoblastoma .h 1877 to 2582 1 to 702       702/877
(80 %)
21 diff
(97.7 %id)
C04144 heart .h 1907 to 2127 1 to 223       223/223
(100 %)
2 diff
(99.2 %id)
AW961882   .h 2040 to 2192 8 to 160       153/188
(81 %)
8 diff
(95.8 %id)
T08568   .h 2044 to 2434 1 to 391       391/391
(100 %)
1 diff
(99.8 %id)
BE174933 head_neck .h 2046 to 2165 125 to 5     Submitted on the opposite strand 121/140
(86 %)
0 diff
(100 %id)
BM698156 eye, fetal eyes .h 2052 to 2663 1 to 612       612/612
(100 %)
0 diff
(100 %id)
BQ424038 eye, retinoblastoma .h 2114 to 2935 1 to 831       831/911
(91 %)
17 diff
(98.2 %id)
W27042 eye, retina .h 2115 to 2532 96 to 514       419/518
(80 %)
1 diff
(99.9 %id)
BE259526 brain, neuroblastoma .h 2158 to 2923 1 to 764       764/813
(93 %)
34 diff
(95.9 %id)
BG897439 cartilage .h 2171 to 2475 86 to 390       305/321
(95 %)
6 diff
(98.2 %id)
R61480 whole brain .h 2176 to 2574 1 to 403       403/533
(75 %)
9 diff
(98.4 %id)
BQ437350 leiomyosarcoma, uterus .h 2246 to 3076 1 to 842       842/920
(91 %)
22 diff
(97.7 %id)
W39391 parathyroid gland, parathyroid tumor .h 2257 to 2657 1 to 400       400/401
(99 %)
6 diff
(98.6 %id)
H17688 whole brain .h 2278 to 2698 1 to 425       425/425
(100 %)
5 diff
(98.9 %id)
R35189 whole brain .h 2279 to 2694 1 to 425       425/467
(91 %)
19 diff
(96.0 %id)
BM806297 leiomyosarcoma, uterus .h 2317 to 3183 12 to 878       867/1071
(80 %)
16 diff
(98.6 %id)
DA511728 brain .h 2320 to 2855 2 to 535   fully sequenced, capped   534/534
(100 %)
3 diff
(99.5 %id)
F11239 brain, total brain .h 2370 to 2670 1 to 301       301/301
(100 %)
0 diff
(100 %id)
H28836 whole brain .h 2370 to 2698 1 to 330       330/330
(100 %)
6 diff
(98.2 %id)
BE179867 head_neck .h 2371 to 2779 425 to 16     Submitted on the opposite strand 410/425
(96 %)
0 diff
(100 %id)
CD675176 eye, lens .h 2378 to 2988 1 to 611       611/611
(100 %)
0 diff
(100 %id)
BM705635 eye, lens .h 2388 to 2769 1 to 382       382/382
(100 %)
0 diff
(100 %id)
BM728484 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 2417 to 3148 730 to 1     Submitted on the opposite strand 730/730
(100 %)
6 diff
(99.2 %id)
BG577052 breast, mammary adenocarcinoma, cell line .h 2419 to 3204 1 to 784       784/784
(100 %)
7 diff
(99.2 %id)
N39676 melanocyte .h 2435 to 2908 1 to 484       484/491
(98 %)
20 diff
(96.0 %id)
AL567894 brain, fetal brain .h 2445 to 3373 906 to 1   fully sequenced,   906/906
(100 %)
4 diff
(99.6 %id)
BI194257 epithelioid carcinoma cell line, Pancreas .h 2520 to 3023 1 to 500       500/730
(68 %)
13 diff
(98.3 %id)
BI194057 epithelioid carcinoma cell line, Pancreas .h 2520 to 3279 1 to 756       756/756
(100 %)
25 diff
(96.7 %id)
BI457361 epithelioid carcinoma cell line, Pancreas .h 2520 to 3292 1 to 756       756/868
(87 %)
36 diff
(95.9 %id)
BI457018 epithelioid carcinoma cell line, Pancreas .h 2520 to 3204 1 to 672       672/672
(100 %)
14 diff
(98.0 %id)
TI_45133607   .h 2521 to 3292 64 to 818       755/867
(87 %)
36 diff
(95.9 %id)
TI_45133805   .h 2521 to 3204 57 to 727       671/671
(100 %)
13 diff
(98.1 %id)
BQ961686 epithelioid carcinoma cell line, Pancreas .h 2522 to 3251 1 to 736       736/977
(75 %)
13 diff
(98.7 %id)
BE799771 lung, small cell carcinoma .h 2545 to 3284 25 to 753       729/985
(74 %)
19 diff
(98.1 %id)
BF953693 nervous_normal .h 2548 to 2723 12 to 185       174/185
(94 %)
6 diff
(96.8 %id)
BM693797 eye, lens .h 2548 to 3130 1 to 583   fully sequenced,   583/583
(100 %)
0 diff
(100 %id)
BF886556 testis_normal .h 2554 to 2924 371 to 1     Submitted on the opposite strand 371/371
(100 %)
2 diff
(99.5 %id)
BM543377 duodenal adenocarcinoma, cell line, small intestine .h 2575 to 3430 891 to 23   AAA Submitted on the opposite strand 869/1035
(83 %)
36 diff
(96.6 %id)
AW897849 nervous_normal .h 2642 to 2779 169 to 28       142/169
(84 %)
0 diff
(100 %id)
TI_57189949   .h 2647 to 3269 59 to 679       621/622
(99 %)
5 diff
(99.2 %id)
BI860124 breast, mammary adenocarcinoma, cell line .h 2648 to 3269 1 to 620       620/621
(99 %)
5 diff
(99.2 %id)
BU623894 cell lines, Enchondroma .h 2681 to 3430 767 to 19   AAA   749/749
(100 %)
1 diff
(99.9 %id)
BE718167 head_neck .h 2710 to 3130 1 to 421       421/421
(100 %)
6 diff
(98.6 %id)
BE718141 head_neck .h 2716 to 3132 7 to 424       418/424
(98 %)
2 diff
(99.6 %id)
BF364780 nervous_normal .h 2718 to 3121 407 to 1       407/407
(100 %)
13 diff
(96.9 %id)
AA446442   .h 2721 to 3086 1 to 364   fully sequenced,   364/364
(100 %)
2 diff
(99.5 %id)
BX096569   .h 2722 to 3369 1 to 647       647/647
(100 %)
4 diff
(99.4 %id)
C03612 heart .h 2724 to 2910 1 to 189       189/189
(100 %)
2 diff
(99.0 %id)
BQ008085 Chondrosarcoma, Left Pelvis .h 2744 to 3430 705 to 19   AAA   687/692
(99 %)
10 diff
(98.6 %id)
TI_154102435   .h 2780 to 3427 716 to 80   AAA   637/790
(80 %)
13 diff
(98.4 %id)
AJ711651 heart .h 2794 to 3167 1 to 375       375/375
(100 %)
2 diff
(99.5 %id)
DB316342 brain .h 2825 to 3420 596 to 1   fully sequenced,   596/596
(100 %)
3 diff
(99.5 %id)
AW972580   .h 2833 to 3419 588 to 1     Submitted on the opposite strand 588/588
(100 %)
14 diff
(97.7 %id)
CK299088 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 2839 to 3430 610 to 19   AAA   592/601
(98 %)
1 diff
(99.9 %id)
TI_151809086   .h 2839 to 3430 79 to 670   AAA   592/592
(100 %)
0 diff
(100 %id)
BP375918 uterus .h 2842 to 3423 1 to 581       581/581
(100 %)
6 diff
(99.0 %id)
BU161141 melanotic melanoma, cell line, skin .h 2862 to 3201 1 to 341       341/1012
(33 %)
2 diff
(99.9 %id)
AI829795 Prostate .h 2866 to 3430 565 to 1       565/565
(100 %)
2 diff
(99.7 %id)
CA445515 Chondrosarcoma, Left Pubic Bone .h 2878 to 3427 567 to 19   AAA   549/549
(100 %)
1 diff
(99.9 %id)
DB297259 cerebellum .h 2887 to 3427 541 to 1       541/541
(100 %)
2 diff
(99.7 %id)
BU734919 eye, lens .h 2904 to 3420 535 to 19   AAA   517/517
(100 %)
3 diff
(99.5 %id)
AI934476 anaplastic oligodendroglioma, brain .h 2911 to 3431 526 to 6       521/526
(99 %)
0 diff
(100 %id)
TI_151739101   .h 2924 to 3427 582 to 81   AAA   502/991
(50 %)
33 diff
(96.7 %id)
BU737575 eye, lens .h 2932 to 3430 517 to 19   AAA   499/499
(100 %)
2 diff
(99.6 %id)
AI813367 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .h 2937 to 3431 497 to 3       495/497
(99 %)
0 diff
(100 %id)
DB550173 hippocampus .h 2949 to 3426 1 to 478     Submitted on the opposite strand 478/478
(100 %)
2 diff
(99.6 %id)
AI480063 anaplastic oligodendroglioma, brain .h 2952 to 3431 487 to 8       480/487
(98 %)
0 diff
(100 %id)
BM673101 eye, optic nerve .h 2953 to 3427 494 to 19   AAA   476/476
(100 %)
8 diff
(98.4 %id)
BU735956 eye, fetal eyes .h 2968 to 3430 481 to 19   AAA   463/463
(100 %)
3 diff
(99.4 %id)
BG059630 brain, glioblastoma without EGFR amplification .h 2974 to 3431 458 to 1       458/458
(100 %)
1 diff
(99.8 %id)
AI870509 anaplastic oligodendroglioma, brain .h 2977 to 3431 456 to 2       455/456
(99 %)
0 diff
(100 %id)
AI948543 anaplastic oligodendroglioma, brain .h 2977 to 3430 454 to 1       454/457
(99 %)
3 diff
(99.4 %id)
DB549459 hippocampus .h 2978 to 3426 1 to 449     Submitted on the opposite strand 449/449
(100 %)
1 diff
(99.8 %id)
AI204694 heart .h 2988 to 3421 435 to 2       434/435
(99 %)
0 diff
(100 %id)
AI826081 anaplastic oligodendroglioma, brain .h 2999 to 3430 449 to 17   AAA   433/433
(100 %)
3 diff
(99.4 %id)
AA506523 breast .h 3017 to 3421 408 to 5       404/408
(99 %)
0 diff
(100 %id)
BM929843 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .h 3043 to 3420 1 to 378   AAA   378/378
(100 %)
0 diff
(100 %id)
BF947872 nervous_normal .h 3045 to 3328 299 to 17       283/299
(94 %)
0 diff
(100 %id)
AA037837 heart .h 3052 to 3329 1 to 280       280/285
(98 %)
9 diff
(96.9 %id)
AA446135   .h 3056 to 3433 378 to 1   fully sequenced,   378/378
(100 %)
7 diff
(98.2 %id)
W15323 parathyroid gland, parathyroid tumor .h 3061 to 3314 278 to 25       254/278
(91 %)
0 diff
(100 %id)
AI339862   .h 3078 to 3431 356 to 3       354/356
(99 %)
0 diff
(100 %id)
T17421   .h 3080 to 3427 348 to 1       348/348
(100 %)
3 diff
(99.2 %id)
BM129101 Islets of Langerhans, Pancreas .h 3088 to 3325 1 to 238       238/238
(100 %)
3 diff
(98.8 %id)
R58935   .h 3095 to 3430 336 to 1       336/347
(96 %)
2 diff
(99.5 %id)
BU738237 eye, lens .h 3100 to 3430 349 to 19   fully sequenced, AAA   331/331
(100 %)
1 diff
(99.7 %id)
AI264806 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h 3104 to 3429 326 to 1       326/326
(100 %)
5 diff
(98.5 %id)
AI659910 Prostate .h 3110 to 3430 343 to 23   AAA   321/321
(100 %)
5 diff
(98.5 %id)
AI160722 brain, glioblastoma (pooled) .h 3120 to 3430 342 to 32   AAA   311/311
(100 %)
14 diff
(95.5 %id)
T17459   .h 3155 to 3430 278 to 1       278/278
(100 %)
4 diff
(98.6 %id)
F08902 brain, total brain .h 3161 to 3430 270 to 1       270/270
(100 %)
1 diff
(99.7 %id)
AA962256 carcinoid, lung .h 3169 to 3427 258 to 1       258/258
(100 %)
2 diff
(99.3 %id)
BQ223193 embryonal carcinoma, cell line, testis .h 3206 to 3426 1 to 221   AAA   221/221
(100 %)
3 diff
(98.7 %id)
R61481 whole brain .h 3218 to 3430 237 to 23   AAA   215/215
(100 %)
6 diff
(97.3 %id)
AI290779 carcinoid, lung .h 3238 to 3427 212 to 23   AAA   190/190
(100 %)
0 diff
(100 %id)
CR747290 brain, hippocampus .h 3255 to 3430 204 to 28   AAA Submitted on the opposite strand 177/177
(100 %)
2 diff
(98.9 %id)
T17295   .h 3267 to 3427 161 to 1       161/161
(100 %)
1 diff
(99.4 %id)
R50849 whole brain .h 3269 to 3430 197 to 37   AAA   161/161
(100 %)
1 diff
(99.4 %id)
NM_213568.1   .i 1 to 2985 1 to 2985 exact RefSeq, AAA   2985/2985
(100 %)
0 diff
(100 %id)
BQ427682 leiomyosarcoma, uterus .i 21 to 893 11 to 883       873/883
(98 %)
10 diff
(98.9 %id)
DB074936 testis .i 24 to 485 2 to 463   capped   462/462
(100 %)
0 diff
(100 %id)
DA392939 thalamus .i 26 to 613 2 to 589   tiling clone, capped   588/588
(100 %)
0 diff
(100 %id)
BP269664 thyroid .i 29 to 610 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA158623 amygdala .i 30 to 592 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA407100 thalamus .i 30 to 561 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
DA443490 tongue, tumor tissue .i 30 to 628 2 to 600   capped   599/599
(100 %)
0 diff
(100 %id)
DA541712 lung .i 34 to 616 2 to 585   capped   584/588
(99 %)
3 diff
(99.5 %id)
DA578900   .i 34 to 580 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA790291 brain .i 34 to 488 2 to 456   capped   455/455
(100 %)
1 diff
(99.8 %id)
DA653049   .i 39 to 610 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
BC020571 Duodenum, adenocarcinoma .i 49 to 2985 17 to 2953 exact tiling clone, available from MGC, AAA   2937/2937
(100 %)
2 diff
(100.0 %id)
BF983086 duodenal adenocarcinoma, cell line, small intestine .i 49 to 765 29 to 764   available from MGC,   736/895
(82 %)
46 diff
(94.9 %id)
BM471457 leiomyosarcoma, uterus .i 59 to 778 1 to 735       735/1247
(58 %)
35 diff
(97.2 %id)
DB142249 thymus .i 59 to 491 2 to 435   capped   434/441
(98 %)
3 diff
(99.4 %id)
DA160906 amygdala .i 61 to 635 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA208574 brain .i 61 to 631 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DA652972   .i 61 to 605 2 to 547   capped   546/546
(100 %)
2 diff
(99.7 %id)
DA909378   .i 61 to 637 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DB008696 cervix, tumor tissue .i 61 to 630 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DB158295 thymus .i 61 to 648 2 to 589   capped   588/588
(100 %)
3 diff
(99.5 %id)
DB170656 kidney, tumor tissue .i 61 to 587 2 to 528   capped   527/527
(100 %)
0 diff
(100 %id)
DA206221 brain .i 63 to 603 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
DA482828   .i 63 to 648 2 to 587   capped   586/586
(100 %)
1 diff
(99.9 %id)
BM755458 stomach .i 64 to 529 1 to 462       462/462
(100 %)
5 diff
(99.0 %id)
BM048385 carcinoma, cell line, Prostate .i 68 to 559 1 to 491       491/491
(100 %)
1 diff
(99.8 %id)
BQ952938 carcinoma, cell line, Prostate .i 70 to 801 1 to 743       743/937
(79 %)
30 diff
(96.8 %id)
BU541514 carcinoma, cell line, Prostate .i 70 to 925 1 to 860       860/870
(98 %)
5 diff
(99.5 %id)
DA748569   .i 70 to 629 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
BE273855 Kidney, renal cell adenocarcinoma .i 74 to 539 11 to 476       466/476
(97 %)
6 diff
(98.8 %id)
TI_1948238623   .i 254 to 571 128 to 445       318/1463
(21 %)
2 diff
(99.9 %id)
EL733614 mixed .i 255 to 571 1 to 317       317/485
(65 %)
1 diff
(99.8 %id)
TI_1948238855   .i 276 to 571 892 to 590     Submitted on the opposite strand 303/1382
(21 %)
0 diff
(100 %id)
BG675747 skin, squamous cell carcinoma .i 561 to 1431 1 to 872       872/873
(99 %)
16 diff
(98.2 %id)
BP254477 Kidney .i 593 to 1170 1 to 579       579/579
(100 %)
10 diff
(98.3 %id)
BQ352566 head_neck .i 911 to 1233 324 to 1       324/324
(100 %)
4 diff
(98.8 %id)
DA271730 caudate nucleus .i 1084 to 1633 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
H07015 whole brain .i 1135 to 1664 1 to 528       528/532
(99 %)
14 diff
(97.4 %id)
BQ651676 hepatocellular carcinoma, cell line, Liver .i 1185 to 2064 1 to 893 R105G V108G L110P A111G     893/962
(92 %)
30 diff
(96.9 %id)
DA598305   .i 1274 to 1834 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
CF139192 CNCAP(3)T-225 cell line, Prostate .i 1569 to 2028 1 to 460       460/460
(100 %)
6 diff
(98.7 %id)
TI_154169404   .i 1576 to 2074 81 to 579       499/499
(100 %)
1 diff
(99.8 %id)
BM476739 leiomyosarcoma, uterus .i 1601 to 2509 10 to 925       916/1106
(82 %)
41 diff
(96.3 %id)
CF146943 CNCAP(3)T-225 cell line, Prostate .i 1631 to 2329 1 to 696       696/696
(100 %)
6 diff
(99.2 %id)
TI_154179484   .i 1634 to 2497 68 to 925       858/858
(100 %)
16 diff
(98.2 %id)
BC017009 Kidney, hypernephroma .i 1642 to 2988 1 to 1347   tiling clone, available from MGC, AAA   1347/1347
(100 %)
0 diff
(100 %id)
AA984627 schizophrenic brain S-11 frontal lobe .i 1643 to 2019 376 to 1       376/376
(100 %)
2 diff
(99.5 %id)
BG166732 hypernephroma, cell line, Kidney .i 1643 to 2343 1 to 702   available from MGC,   702/704
(99 %)
9 diff
(98.8 %id)
AA377752 synovial membrane .i 1699 to 2016 1 to 318       318/319
(99 %)
1 diff
(99.7 %id)
TI_154197386   .i 1754 to 2248 121 to 622       502/1078
(46 %)
53 diff
(95.1 %id)
TI_154195753   .i 1761 to 2622 11 to 860       850/1036
(82 %)
7 diff
(99.4 %id)
TI_227712416   .i 2003 to 2985 1048 to 78   AAA   971/1060
(91 %)
30 diff
(97.2 %id)
TI_154135356   .i 2101 to 2983 955 to 80   AAA   876/980
(89 %)
18 diff
(98.2 %id)
AA176525.
matches multiple genes
muscle, skeletal muscle .i 2221 to 2666 1 to 451     also hits gene HFE2 451/451
(100 %)
5 diff
(98.9 %id)
BQ019060 lung, Metastatic Chondrosarcoma .i 2310 to 2983 691 to 17   AAA   675/690
(97 %)
2 diff
(99.8 %id)
BM725926 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .i 2394 to 2969 1 to 576       576/576
(100 %)
0 diff
(100 %id)
BU620748 cell lines, Chondrosarcoma .i 2429 to 2983 572 to 19   AAA   554/554
(100 %)
2 diff
(99.7 %id)
CD367123 Alveolar Macrophage, lung .i 2430 to 2985 571 to 17   AAA   555/555
(100 %)
3 diff
(99.5 %id)
AI814479 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .i 2496 to 2985 490 to 1       490/490
(100 %)
1 diff
(99.8 %id)
F28813 pectoral muscle (after mastectomy) .i 2501 to 2920 1 to 419       419/419
(100 %)
1 diff
(99.8 %id)
F37187 pectoral muscle (after mastectomy) .i 2507 to 2808 1 to 302       302/304
(99 %)
1 diff
(99.7 %id)
AW300964 colon, moderately differentiated adenocarcinoma .i 2518 to 2988 479 to 9       471/479
(98 %)
0 diff
(100 %id)
AI700679 carcinoid, lung .i 2521 to 2986 466 to 1       466/466
(100 %)
1 diff
(99.8 %id)
H05464 whole brain .i 2533 to 2988 483 to 22   AAA   462/463
(99 %)
11 diff
(97.7 %id)
BE048533 Kidney .i 2552 to 2988 437 to 1       437/444
(98 %)
0 diff
(100 %id)
AW300669 colon, moderately differentiated adenocarcinoma .i 2558 to 2983 441 to 16   AAA   426/426
(100 %)
2 diff
(99.6 %id)
AW294494   .i 2636 to 2985 365 to 16   AAA   350/350
(100 %)
0 diff
(100 %id)
BC000815 Placenta, choriocarcinoma .i 2639 to 2985 1 to 347   available from MGC, AAA   347/347
(100 %)
0 diff
(100 %id)
BE542301 cervix .i 2659 to 2986 1 to 325   available from MGC,   325/325
(100 %)
4 diff
(98.8 %id)
T23724   .i 2741 to 2985 249 to 5       245/249
(98 %)
0 diff
(100 %id)
DA117223 cerebellum .j 1 to 544 2 to 545 exact tiling clone, capped   544/546
(99 %)
1 diff
(99.9 %id)
AK002044 placenta Gene SLC39A3andDIRAS1, variant not shown       available from FLJ, Suspected internal deletion, this clone was ignored    
BX387458 Neuroblastoma Cot 25-normalized Gene SLC39A3andDIRAS1, variant not shown         This clone was ignored    
BX387459 Neuroblastoma Cot 25-normalized Gene SLC39A3andDIRAS1, variant not shown         This clone was ignored    
AA535975 colon Gene SLC39A3andDIRAS1, variant not shown         Suspected internal deletion, this clone was ignored    
AI076903 B-cell, chronic lymphotic leukemia Gene SLC39A3andDIRAS1, variant not shown         Suspected internal deletion, this clone was ignored    
AI962249 pooled germ cell tumors Gene SLC39A3andDIRAS1, variant not shown         This clone was ignored    
BC089431 Lymph, normal germinal center B cells Gene SLC39A3andDIRAS1, variant not shown       AAA This clone was ignored    
CF121471 lymph Gene SLC39A3andDIRAS1, variant not shown         This clone was ignored    
BE502063 pooled germ cell tumors Gene SLC39A3andDIRAS1, variant not shown         This clone was ignored    
BG472680 eye, retinoblastoma Gene SLC39A3andDIRAS1, variant not shown       AAA This clone was ignored    
BG479533 choriocarcinoma, placenta Gene SLC39A3andDIRAS1, variant not shown         This clone was ignored    
BM906285 ovary (pool of 3) Gene SLC39A3andDIRAS1, variant not shown       AAA This clone was ignored    
AU157366 placenta Gene SLC39A3andDIRAS1, variant not shown         Suspected internal deletion, this clone was ignored    
AU137908 placenta Gene SLC39A3andDIRAS1, variant not shown       capped Suspected internal deletion, this clone was ignored    
TI_154180567   Gene SLC39A3andDIRAS1, variant not shown         This clone was ignored    
BM663937 eye, Retina Foveal and Macular Gene SLC39A3andDIRAS1, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BU634077 cell lines, Chondrosarcoma Gene SLC39A3andDIRAS1, variant not shown       AAA Suspected internal deletion, this clone was ignored    
TI_151766070   Gene SLC39A3andDIRAS1, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c-u, .d, .e, .f, .g, .h, .i, .j Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC